Stephen P. Carey
2017
In 2017, Stephen P. Carey earned a total compensation of $1.2M as Vice President, Finance and Chief Financial Officer at ANI Pharmaceuticals, a 15% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $180,000 |
|---|---|
| Option Awards | $341,320 |
| Salary | $389,233 |
| Stock Awards | $328,004 |
| Other | $8,000 |
| Total | $1,246,557 |
Carey received $389.2K in salary, accounting for 31% of the total pay in 2017.
Carey also received $180K in non-equity incentive plan, $341.3K in option awards, $328K in stock awards and $8K in other compensation.
Rankings
In 2017, Stephen P. Carey's compensation ranked 7,921st out of 14,666 executives tracked by ExecPay. In other words, Carey earned more than 46.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,921 out of 14,666 | 46th |
Division Manufacturing | 2,972 out of 5,772 | 49th |
Major group Chemicals And Allied Products | 973 out of 2,075 | 53rd |
Industry group Drugs | 759 out of 1,731 | 56th |
Industry Pharmaceutical Preparations | 596 out of 1,333 | 55th |
Source: SEC filing on April 6, 2018.
Carey's colleagues
We found three more compensation records of executives who worked with Stephen P. Carey at ANI Pharmaceuticals in 2017.
News
ANI Pharmaceuticals CEO Nikhil Lalwani's 2021 pay jumps 76% to $6.5M
March 25, 2022
ANI Pharmaceuticals CEO Nikhil Lalwani receives $3.7M in 2020
April 29, 2021
ANI Pharmaceuticals CEO Arthur Przybyl's 2019 pay jumps 39% to $5.8M
April 23, 2020
ANI Pharmaceuticals CEO Arthur Przybyl's 2018 pay rises 17% to $4.2M
April 4, 2019